SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adamas Pharmaceuticals, Inc. - ADMS

NEW YORK, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (Adamas or the Company) (NASDAQ: ADMS) Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.